Strong policy push! The market for such medical materials has exceeded the 300 billion mark!

Strong policy push

The scale of biomaterials exceeded the 300 billion mark

With economic development and the improvement of people's quality of life, in recent years, people's demand for biomedical materials is increasing.

According to the "2017-2021 China Biomedical Materials Industry Investment Analysis and Prospect Forecast Report", the market size of my country's biomedical materials has increased from 65 billion yuan in 2011 to 240 billion yuan in 2018, achieving a nearly 4-fold increase .

Market size of biomedical materials in my country from 2011 to 2021 (100 million yuan)

Data source: CIC Consultants

Especially under the guidance of the national "14th Five-Year Plan" "to accelerate the development of biomedicine and other industries, and to expand and strengthen the bio-economy"; and "Made in China 2025" to "vigorously promote the breakthrough development of biomedicine and high-performance medical devices" and other policies. In the future, the market size of biomedical materials is destined to exceed the 300 billion yuan and 3.5 trillion yuan mark.

surge in demand

Medical adhesives usher in good opportunities for agents

Among the new medical materials, medical adhesives that can be used in the field of "wound closure" have been welcomed by both doctors and patients.

Compared with the traditional wound closure method, the use of medical adhesives does not require needle and thread sutures, and does not require secondary suture removal. It is not easy to form heavier suture scars (centipede-shaped suture scars), and the operation is more convenient and safer to use.

It is worth mentioning that medical adhesives are also known as the "golden partner" of minimally invasive surgery in the industry. Today, the number of minimally invasive surgical operations in my country has increased from 4,248 in 2015 to 8,514 in 2019, with a penetration rate of nearly 40%. , Under this trend, the market demand for medical adhesives will continue to increase!

On the other hand, the National "Thirteenth Five Year" Medical Device Technology Innovation Special Plan also pointed out that it is necessary to "lead screening and early warning, early diagnosis, micro/non-invasive treatment and other new medical products to fully realize localization, reduce import dependence, reduce medical cost". This means that in my country's postoperative care market in the future, the process of domestic substitution of biomaterials will surely be accelerated.